110 results on '"Schmidt, Ann Marie"'
Search Results
2. Time to Give Thanks and Welcome New Members to the Editorial Team.
3. Honoring the Life and Legacy of Dr David A. Dichek.
4. Introducing Socrates' Corner to ATVB Journal: Critical Appraisals of Animal Models of Disease.
5. Academic-Industry Partnerships: Transparency, Potential Conflict of Interest, and Communicating State-of-the-Art Technologies.
6. Silencing Myeloid Netrin-1 Induces Inflammation Resolution and Plaque Regression.
7. Recipients of the 2024 Early Career Investigator Awards.
8. MicroRNA-33 Inhibits Adaptive Thermogenesis and Adipose Tissue Beiging.
9. Journey to a Receptor for Advanced Glycation End Products Connection in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: With Stops Along the Way in the Lung, Heart, Blood Vessels, and Adipose Tissue.
10. S100A9-RAGE Axis Accelerates Formation of Macrophage-Mediated Extracellular Vesicle Microcalcification in Diabetes Mellitus.
11. An Eclectic Cast of Cellular Actors Orchestrates Innate Immune Responses in the Mechanisms Driving Obesity and Metabolic Perturbation.
12. Leukocyte Heterogeneity in Adipose Tissue, Including in Obesity.
13. Annual Report on Sex in Preclinical Studies: Arteriosclerosis, Thrombosis, and Vascular Biology Publications in 2018.
14. Metabolism, Obesity, and Diabetes Mellitus: Recent Studies in Cellular and Animal Models and Human Subjects Highlight Mechanisms and Consequences of Metabolic Dysfunction.
15. Diabetes Mellitus and Cardiovascular Disease: Emerging Therapeutic Approaches.
16. Highlighting Diabetes Mellitus: The Epidemic Continues.
17. ATVB : Entering the Next Era.
18. Ager Deletion Enhances Ischemic Muscle Inflammation, Angiogenesis, and Blood Flow Recovery in Diabetic Mice.
19. 2016 ATVB Plenary Lecture.
20. Recipients of the 2023 Early Career Investigator Awards.
21. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
22. The Growing Problem of Obesity.
23. Glycation and Insulin Resistance.
24. Formin mDia1 Mediates Vascular Remodeling via Integration of Oxidative and Signal Transduction Pathways.
25. Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis.
26. Activation of the ROCK1 Branch of the Transforming Growth Factor-ß Pathway Contributes to RAGE-Dependent Acceleration of Atherosclerosis in Diabetic ApoE-Null Mice.
27. The RAGE Axis: A Fundamental Mechanism Signaling Danger to the Vulnerable Vasculature.
28. S100A4 and Bone Morphogenetic Protein-2 Codependently Induce Vascular Smooth Muscle Cell Migration via Phospho—Extracellular Signal-Regulated Kinase and Chloride Intracellular Channel 4.
29. Anti-Receptor for Advanced Glycation End Products Therapies as Novel Treatment for Abdominal Aortic Aneurysm.
30. Oxygen Deprivation Triggers Upregulation of Early Growth Response-1 by the Receptor for Advanced Glycation End Products.
31. Interdependent Serotonin Transporter and Receptor Pathways Regulate S100A4/Mts1, a Gene Associated With Pulmonary Vascular Disease.
32. Central Role of PKCβ in Neointimal Expansion Triggered by Acute Arterial Injury.
33. Protein Glycation.
34. Early Growth Response-1 Promotes Atherogenesis.
35. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice.
36. Glycation, Inflammation, and RAGE.
37. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.
38. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.
39. Activation of Receptor for Advanced Glycation End Products.
40. Stopping the primal RAGE reaction in myocardial infarction: capturing adaptive responses to heal the heart?
41. Sphingosine-1-Phosphate.
42. Hyperinsulinemia and Vascular Dysfunction.
43. Complying With the National Institutes of Health Guidelines and Principles for Rigor and Reproducibility Refutations.
44. Reporting Sex and Sex Differences in Preclinical Studies.
45. Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332.
46. Response by Daugherty et al to Letter Regarding Article, “Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies: A Statement From the Arteriosclerosis, Thrombosis, and Vascular Biology Council”.
47. Insulin Resistance and Metabolic Syndrome.
48. Selective Anticoagulation With Active Site Blocked Factor IXa in Synthetic Patch Vascular Repair Results in Decreased Blood Loss and Operative Time.
49. Unveiling Intriguing Links Between Limb Ischemia, Systemic Inflammation, and Progressive Atherosclerosis: A Tangled and Interconnected Web.
50. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.